Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Cash from Operations (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Cash from Operations data on record, last reported at 412000000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations changed N/A year-over-year to 412000000.0; the TTM value through Dec 2025 reached 612000000.0, changed N/A, while the annual FY2025 figure was 482000000.0, 183.53% down from the prior year.
  • Cash from Operations reached 412000000.0 in Q4 2025 per RCUS's latest filing, down from 132000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 654000000.0 in Q1 2022 and bottomed at 412000000.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 43411764.71, with a median of 66316000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: soared 1086.19% in 2022, then plummeted 6500.0% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 61932000.0 in 2021, then decreased by 13.03% to 70000000.0 in 2022, then decreased by 25.71% to 88000000.0 in 2023, then surged by 129.55% to 26000000.0 in 2024, then plummeted by 1684.62% to 412000000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 412000000.0 in Q4 2025, 132000000.0 in Q1 2025, and 26000000.0 in Q3 2024.